Skip to content
healthcare.dev
Get a free key

RyVent

NDC 15370-130, carbinoxamine maleate, tablet, from Carwin Pharmaceutical Associates, LLC.

Product NDC
15370-130
Status
Listed
Labeler
Carwin Pharmaceutical Associates, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207484
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/15370-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBINOXAMINE MALEATE6 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
15370-130-02153700130022 TABLET in 1 BOTTLE, PLASTIC (15370-130-02)
15370-130-1015370013010100 TABLET in 1 BOTTLE, PLASTIC (15370-130-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/13ed76c7-49bd-4527-83dc-b4c7d0da9fff

Use it

Look up 15370-130 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/15370-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 15370-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.